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Abstract 
Compromised bone quality and or healing in osteoporosis are recognised risk factors for 
impaired dental implant osseointegration. This study examined the effects of 1) 
experimentally induced osteoporosis on titanium implant osseointegration and 2) the effect of 
modified implant surface topography on osseointegration under osteoporosis-like conditions. 
Machined and micro-roughened surface implants were placed into the maxillary first molar 
root socket of 64 ovariectomised and sham-operated Sprague-Dawley rats. Subsequent 
histological and SEM observations showed tissue maturation on the micro-rough surfaced 
implants in ovariectomised animals as early as 3 days post-implantation. The degree of 
osseointegration was also significantly higher around the micro-rough implants in 
ovariectomised animals after 14 days of healing although by day 28, similar levels of 
osseointegration were found for all test groups. The micro-rough implants significantly 
increased the early (day 3) gene expression of alkaline phosphatase, osteocalcin, receptor 
activator of nuclear factor kappa-B ligand and dentin matrix protein 1 in implant adherent 
cells. By day 7, the expression of inflammatory genes decreased while the expression of the 
osteogenic markers increased further although there were few statistically significant 
differences between the micro-rough and machined surfaces. Osteocyte morphology was also 
affected by estrogen deficiency with the size of the cells being reduced in trabecular bone. In 
conclusion, estrogen deficiency induced osteoporotic conditions negatively influenced the 
early osseointegration of machined implants while micro-rough implants compensated for 
these deleterious effects by enhancing osteogenic cell differentiation on the implant surface. 
 
Statement of Significance 
Lower bone density, poor bone quality and osseous microstructural changes are all features 
characteristic of osteoporosis likely to impair the osseointegration of dental implants. Using a 
clinically relevant trabecular bone model in the rat maxilla, we demonstrated histologically 
that the negative effects of surgically-induced osteoporosis on osseointegration could be 
ameliorated by the biomaterial’s surface topography. Furthermore, gene expression analysis 
suggests this may be a result of enhanced osteogenic cell differentiation on the implant 
surface. 
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1. Introduction 
Osteoporosis is a chronic disease affecting over 200 million people worldwide [1]. 
Osteoporosis in the elderly, especially postmenopausal women is also significantly correlated 
with tooth loss [2-5]. Lower bone density, poor bone quality and osseous microstructural 
changes, all characteristics of osteoporosis, have been shown to delay the bone healing 
process of fractured bone [6-8]. Endosseous dental implant healing exhibits similar biological 
mechanisms to that observed in bone fracture healing [9-12], and hence may be influenced by 
osteoporotic conditions.  The results of a recent systematic review show that osteoporotic 
patients have higher rates of dental implant loss [13]. Many animal studies have reported a 
lower rate of titanium implant osseointegration in osteoporotic environments, however the 
majority of these studies used long bone [14-18] rather than jaw bone models [19].  As there 
are significant differences in the embryological origin, ossification process and the response 
to osteoporotic conditions between long bones and craniofacial bones [20, 21], the relevance 
of results obtained in a long bone model to the oral environment is questionable. We have 
shown that the bone quality in the posterior rat maxilla is negatively affected by estrogen 
deficiency induced osteoporotic conditions [22], and that the first molar site in the posterior 
maxilla is a suitable model for dental implant research [23].  
Early studies in the jawbone using an osteoporotic rat model showed no significant 
influence on osseointegration when using first-generation ‘machined’ implants [24-26]. 
However,  contemporary implants have a ‘micro-rough’ implant topography which is known 
to influence peri-implant bone healing [27]. Indeed animal studies have shown that 
commercially available ‘micro-rough’ surfaced titanium implants result in superior bone to 
implant contact compared to ‘smoother’ machined surfaced implants  [28, 29], as well as 
having superior torque removal values [30, 31]. Few studies have evaluated the influence of 
titanium implant surface topography on the early stages of bone healing during 
osseointegration under osteoporotic conditions [32, 33]. Furthermore, the underlying cellular 
and molecular mechanisms that may be influenced by surface topography during 
osseointegration under osteoporotic conditions are not well understood. 
Therefore, in this study, the primary aim was to test the hypothesis that estrogen 
deficiency has a negative  influence on implant healing which can be ameliorated by micro-
rough implant surface topography. A secondary objective was to undertake ultrastructural and 
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gene expression analysis to elucidate the cellular and molecular mechanisms that may be 
influenced under these conditions. 
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2. Material and Methods 
2.1. Animals 
The Griffith University animal ethics committee approved the experimental protocol for 
the study (DOH/01/4/AEC). Sixty four three-month-old female Sprague-Dawley rats (Animal 
Resource Center,Western Australia) were used. This number of animals was chosen based on 
the results of histomorphometric analysis in similar studies using ovariectomised rats [15, 23]. 
Animals were fed standard rat chow and water ad libitum throughout the experiment. After 
acclimatization for 2 weeks, the rats were randomly divided into two groups, sham-operated 
(SHAM, n=32) and ovariectomised (OVX, n=32). Ovariectomy was performed according to 
our previously established methods [15, 22] where both histological and micro-CT analyses 
demonstrated successful induction of osteoporosis. SHAM group rats were also subjected to 
the same surgical procedure with an equivalent amount of fat tissue removed instead of the 
ovaries. All of the surgical procedures were performed under isoflurane (1–3%) inhalation 
anaesthesia. The animals were subsequently allowed to develop osteoporosis over three 
months prior to implant placement. This period of time has been shown to be sufficient to 
develop osteoporotic conditions in this model [22]. 
2.2. Implants 
The surface roughness parameter ‘Sa’ (Arithmetic mean height) was analysed under 
20×objective magnification using 3D optical microscopy (Contour Elite 3D, Bruker, US).  
‘minimally-rough’ machined (Sa = 518.7±10.88nm; Sq = 643.4±30.53nm) and ‘micro-rough’ 
(Sa = 906.19±19.85nm; Sq = 1.11±0.09µm) surfaced titanium implants (2mm diameter x 
3mm length) produced from Type IV commercially pure titanium were obtained from 
Southern Implants Ltd (Irene, South Africa). The micro-rough surfaced implant was prepared 
using the same techniques (aluminium oxide blasting)  as used for commercially available 
dental implants [Fig.1]. 
2.3. Surgical Procedures 
One implant of each surface type (machined and micro-rough) was placed bilaterally in 
the maxilla of all 64 animals 3 months after ovariectomy using a previously published 
protocol [23]. Briefly, implants were placed into the first molar mesial socket after tooth 
extraction. The osteotomy was prepared using a 1.2mm pilot drill and a 1.8mm diameter final 
drill (Southern Implants, Ltd., Irene, South Africa). All osteotomy procedures were 
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performed with copious saline irrigation. Machined and rough surfaced implants were placed 
into the prepared sockets with a torque of approximately 15Ncm until the implant shoulder 
was inserted to the level of the bone crest. The wound was then sutured with slowly 
resorbable sutures (5-0 Vicryl Ethicon, NJ, USA). Post-operative analgesia (buprenorphine 
0.01 - 0.05mg/kg and carprofen 4 - 5mg/kg) and antibiotic cover (entrofloxacin 2.5mg/Kg) 
were administrated by intraperitoneal injection immediately after the surgery and continued 
daily for three days post-operatively.  
To identify new bone formation the fluorescent dyes alizarin red S (25mg/kg, 3 days 
before sacrifice) and calcein (10mg/kg, 10 days prior to alizarin injection) were given 
intraperitoneally. Mineral apposition rate (MAR) is calculated as the distance between the 
midpoint of the corresponding edges of the two labels divided by the time between the 
labeling periods [34].  
2.4. Sample Collection  
Animals were sacrificed after 3, 7, 14 and 28 days of healing and samples were collected 
for histological, SEM and qPCR analysis. Five animals per group were used for the PCR 
analyses, while 2 animals per group were used for the histological and scanning electron 
microscopy observations at days 3 and 7, a total of 9 animals (18 implants) for each of the 
four test groups i.e SHAM and OVX; machined and micro-rough. For the longer-term 
healing histological and SEM observations at days 14 and 28, samples were collected from 7 
animals (14 implants) per test group. 
2.5. Histological Sample Preparation  
Using a diamond-tipped circular saw, block sections of the maxilla containing the 
implants were collected and immediately fixed with 4% paraformaldehyde for 48h at 4°C. 
The samples were then dehydrated in a graded series of ethanol before being embedded in 
methylmetacrylate resin (Technovit® 7200 VLC, Heraeus Kulzer, Dormagen, Germany). 
Thirty-micron thick sections of the maxilla containing the implant were prepared using a 
cutting and grinding system  (EXAKT Apparatebau, Norderstedt, Germany) [35]. Two 
sections per implant were stained with methylene blue-alizarin red S and scanned using the 
Aperio ScanScope CS at 40 times magnification (Aperio Technologies Inc., Vista, CA). 
Histomorphometric analysis was carried out using ImageScope software at 4 times 
magnification (Aperio Technologies Inc.) by a single blinded trained examiner.The 
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percentage of bone to implant contact (%BIC) was defined as the ratio of the sum of the 
implant length in direct contact with new bone tissue and the total length of the implant 
adjacent to native bone (each side contained at least two threads). New bone area (%BA) was 
defined as the percentage of mineralized bone tissue within the threaded areas of the implant 
that were adjacent to native bone  [23]. 
 
2.6. Scanning electron microscopy   
 Samples (n=2 in each group) were fixed in 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate buffer (PH 7.4) containing 0.05% tannic acid for at least 48h at 4ºC. The samples 
were then frozen in liquid nitrogen, followed by cryo-fracturing. At the early healing times 
(day3 and day7), as the implant has not fully integrated with bone the cryo-fracture technique 
is an effective method to allow separation of the dental implant from the bone [36]. SEM 
observation was carried using a field emission scanning electron microscope (Carl Zeiss 
Sigma VP Oxford Micro-analysis Field Emission Scanning Electron Microscopy, Germany). 
For SEM analysis of osteocytes, polished resin embedded samples were first acid etched 
with 37% phosphoric acid for 10 seconds then immersed in 5% sodium hypochlorite for 5 
min and air-dried overnight [22, 37]. The sections were subsequently coated with gold prior 
to SEM observation. This analysis was carried out only on the day 28 samples when 
osseointegration is complete and the relationship between osteocytes and the implant can be 
observed. 
2.7. Quantitative RT-PCR 
PCR was performed at days 3 and 7 to assess the early expression of  genes associated 
with the healing microenvironment. After unscrewing the implant from the maxilla, tissue 
from the implant surface and socket wall was collected using a small dental curette and 
immediately immersed into TRIZOL reagent (Invitrogen).  Total RNA was subsequently 
extracted from these samples according to the manufacturer’s instructions. M-MuLV Reverse 
Transcriptase was then used to prepare complementary DNA (cDNA) according to the 
manufacture’s protocols.  
Oligonucleotide primers used to assess osteogenesis (alkaline phosphatase (ALP), 
osteocalcin (OC), alpha-1 type I collagen (COL1A)), osteoclast (receptor activator of nuclear 
factor kappa-B ligand (RANKL), tartrate-resistant acid phosphatase (TRAP)), osteocyte 
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(dentin matrix protein 1 (DMP1), sclerostin (SOST)) and inflammatory marker gene 
expression (tumor necrosis factor-alpha (TNFα), interleukin-1β (IL-1β)) are listed in table 1.  
Real-time PCR reactions (LightCycler 480 Real-Time PCR System, Roche, USA) were run 
using the following parameters: denaturation at 95˚C for 30 s and 40 cycles of amplification 
(95 ˚C for 10 s and 60 ˚C for 20 s). Quantification of gene expression was calculated using 
the delta Ct method and 90% PCR efficiency (k*1.9∆ct) [38]. The expression of the targeted 
genes was normalised using the geometric average of three house-keeping genes (B2M, 
GAPDH and β-actin) [39]. 
2.8. Statistical analysis 
As the data collected at the various time-point was from different animals i.e were not 
repeated measures, Two-way analysis of variance at each individual time point was used to 
assess the effect of the implant surface (machined vs. rough) and treatment group (SHAM vs.  
OVX) on  %BIC, %BA, MAR and relative gene expression. One-way ANOVA at day 28 
only was used to asses any difference in osteocyte body size. A p-value of <0.05 was 
considered significant.  
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3. Results     
3.1 Histologic and SEM analysis of early healing at days 3and 7 
All animals survived the surgical procedures and healing progressed uneventfully. After 3 
days of healing, the cryo-fractured samples showed that more tissue was attached to the 
rough surfaced implants compared with the machined implants in both the SHAM and OVX 
groups [Fig. 2a, d; Fig. 3a, d]. At high magnification, the rough surfaced implants were seen 
to be covered by a layer of mixed tissue including matrix, fibres and cells (blood and 
inflammatory cells) [Fig. 2b; Fig. 3b]. However, on the machined implants, most of the 
surface was exposed or covered with a very thin mixed structure consisting of fibres and 
scattered cells with less amorphous matrix [Fig. 2e; Fig. 3e].  
The morphology of the tissue covering both of the machined and micro-rough implant 
surfaces in the SHAM group revealed a denser consistency of fibres compared with the OVX 
group [Fig. 3b vs. Fig. 2b; Fig. 3e vs. Fig. 2e]. Red blood cells and adherent cells were visible 
on the surface of the implants in both the OVX and SHAM groups at this early stage of 
healing (Day 3).  
Histological analysis revealed that the host bone was in contact with the implants in some 
areas, with fragments of old bone also sparsely distributed within the implant thread 
chambers. Osteoblasts were found to be present at this stage and were more obvious on the 
rough surfaced implants, especially in OVX animals, which showed osteoblasts regularly 
organized near the old bone surface [Fig. 2c]. A small amount of early osseointegration was 
observed on the micro-rough implants in the SHAM treated animals, with a thin layer of new 
bone seen to be forming directly on the implant surface [Fig.3c]. However, overall there was 
no obvious difference between the SHAM and OVX group for both micro-rough and 
machined implants at this early time-point [Fig. 2c, f; Fig. 3c, g].  
Confocal fluorescence analysis at day 3 showed areas of new bone formation within the 
implant surgical site as shown by the uptake of calcein fluorescence by the new bone [Fig. 4]. 
Furthermore, the SHAM group were found to have more new bone formation than the OVX 
group, while micro-rough surfaced implants in the OVX group were associated with more 
new bone formation than machined implants [Fig. 4]. 
By day 7 of healing, under SEM observation, the micro-rough implants were again found 
to have more adherent tissue than the machined implants. The tissue attached to the implant 
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surfaces also seemed denser than it appeared at day 3 [Fig. 5a, d; Fig. 6a, e]. Under high 
magnification, fibers merged with each other to become thicker compared with their 
morphology at day 3 in both the SHAM and OVX groups. The fiber distribution in the 
SHAM group implants was thicker and more regular than the OVX group implants [Fig. 6b 
vs. Fig. 5b; Fig. 6f vs. Fig. 5e]. The rough surfaced implant group also showed more attached 
fibers than the machined implant group [Fig. 5b vs. 5e; Fig. 6b vs. 6f]. Osteoclast-like cells 
could be readily observed among the tissues associated with the OVX rough surfaced 
implants [Fig. 5b].  Red blood cells and adherent cells decreased compared with day 3 but 
still could be observed especially on the OVX machined implants [Fig. 5e].  
Histology showed that new woven bone was formed around both machined and micro-
rough surface implants. The SHAM group formed more bone to implant contact than the 
OVX group [Fig. 6c vs. Fig. 5c; Fig. 6g vs. Fig. 5f], and the micro-rough implant group 
showed more osseointegraton than the machined implant group [Fig. 5c vs. 5f; Fig. 6c vs. 6g]. 
The new bone formed in the SHAM micro-rough implant group [Fig 6c] appeared more 
mature (i.e. histological staining was more intense due to increased mineralisation)  than the 
SHAM machine surface group where the less mineralised tissue stained lighter [Fig 6g], as 
well as both OVX groups [Fig. 5c,f].   New bone formation was also observed at the junction 
of the old bone surface in all groups. Both osteoblasts and osteoclasts could be observed, with 
osteoblasts arranged regularly along the new bone surface [Fig. 6d], and multinuclear 
osteoclasts located in the old bone surface within obvious bone resorption pits [Fig. 6h]. 
3.2. Gene expression 
Two time points (day 3 and day 7) were selected for gene expression analysis of the early 
healing events. Gene markers were divided into four groups: osteogenesis (ALP, OC and 
COL-1A), osteoclast (RANKL and TRAP), osteocyte (DMP1 and SOST) and inflammation 
(TNFa and IL1b). At day 3 (Fig. 7), overall low levels of osteogenesis (ALP and OC), 
osteoclast (TRAP) and osteocyte (DMP1) gene expression was shown to be significantly 
higher on the SHAM micro-rough implants compared to the other groups. Osteoclast 
(RANKL) gene expression was also significantly increased in the OVX micro-rough implant 
group . Furthermore, expression of the osteocyte marker DMP1 was significantly increased in 
both the SHAM and OVX micro-rough implant groups when compared with the machined 
implant groups. 
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By day 7 (Fig. 8), the mean levels of gene expression of ALP, OC, COL-1A, RANKL, 
TRAP, DMP1 and SOST were increased in all groups from the day 3 levels. The osteoclast 
markers RANKL and TRAP were significantly increased in the SHAM micro-rough implant 
group compared with other groups. The osteocyte marker DMP1 was also significantly 
increased in the SHAM micro-rough group while SOST  showed a trend towards increased 
levels at this timepoint. As expected with normal healing and the resolution of inflammation, 
the inflammation markers IL1b and TNFa at 7 days showed decreased expression compared 
to day 3. 
3.3. Histomorphometric analysis of osseointegration at Days 14 and 28 
Histological analysis was also performed on the day 14 and day 28 samples.  At day 14, 
there was a significant amount of new bone around all implants for both the SHAM and OVX 
groups, with active osteoclasts and osteoblasts visible. The osteoblasts were arranged 
regularly around the new bone surface, while in some areas of the old bone, multinuclear 
osteoclasts could be observed in resorption pits (Fig. 9). There was no difference in %BIC 
between the SHAM micro-rough implant group (50.42 ± 2.25)  and the SHAM machined 
implant group (52.95 ± 4.47). In addition, no difference in the %BIC was found between the 
SHAM micro-rough implant group and the OVX rough surfaced implant group (45.54 ± 4.33) 
(Fig. 10c, f). The OVX machined implant group (32.59 ± 2.24) had the least osseointegration 
as measured by %BIC, when compared with the OVX micro-rough implant group  and 
SHAM machined implant group . However, there were no significant differences in %BA 
among the groups [Fig. 9, Fig. 10c, f]. 
At day 28, the new bone formed around the implants appeared to have a more mature and 
dense morphology than at day 14. The %BIC and %BA for all groups increased as expected 
with normal healing and no significant differences were observed between the groups at each 
time-point. Interestingly the %BIC in the OVX machined treatment group which was 
significantly lowere than the other treatment groups at day 14 had also increased to a similar 
level as that seen for the remaining groups by day 28 (Fig. 10c). Osteoblasts were still visible 
around the new bone surfaces however the number appeared fewer than at day 14. The 
mineralized apposition rate (MAR) as determined by fluorescence staining did not show any 
significant differences among the groups [Fig. 11]. 
3.4. Analysis of osteocytes.  
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Using the acid etching technique, SEM analysis of osteocytes in the trabecular bone 
showed that the cell bodies were morphologically smaller in the OVX than in the SHAM 
group, although the lacunae appeared similar (Fig. 12a,c; Fig. 13a,c d, e g ). No difference in 
osteocytes were observed in cortical areas (Fig.13b, f, h). The osteocytes in the new bone 
areas (nearer to the implant) appear disorganized and smaller than the osteocytes in the old 
bone areas [Fig.12a, c]. Osteocytes in trabecular bone areas also show less uniformity than in 
the cortical areas where the osteocytes were arranged in a uniform parallel pattern with an 
elongated cell morphology [Fig. 13a, b, e, f]. The more distal from the new bone the more 
regular the osteocyte arrangement appeared. Osteocytes appeared to be in direct contact with 
the implant surface through dendrite like structures or indirectly through a thin layer of 
matrix which was in contact with the implant [Fig. 12b, d].  
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4. Discussion 
The effect of osteoporosis on the osseointegration of titanium dental implants however 
continues to be a controversial issue [42, 43]. Osteoporosis has been shown to be a risk factor 
for implant failure [42] and it is unclear if this negative effect may be overcome by the use of 
implants with a micro-rough surface topography [44]. Examination of the extent to which 
surface modification can influence healing in a poor quality bone environment through the 
use of an osteoporotic animal model has important clinical implications, especially given the 
extensive incidence of osteoporosis in the general population.  
Most  osteoporotic animal models have utilized long bones, such as the tibia [15, 17, 18, 
45, 46] or femur [16, 47] and the results from these studies is of limited value in 
understanding the osseointegration of endosseous implants into the jaw in osteoporotic 
conditions. Compared with long bone, the jaw bone has a different embryological origin and 
a different ossification mechanism, as well as a different response to estrogen deficiency [48, 
49].  Thus, results from animal models of osteoporosis using the maxilla would be more 
comparable to dental implant osseointegration in osteoporotic patients. The results of this 
study show that both OVX and implant surface morphology affected the early healing events 
around titanium dental implants. 
New bone formation was observed to be scattered in the implant thread chamber areas in 
the SHAM (micro-rough and machined) and OVX rough surface implant groups as identified 
by calcein uptake as early as day 3 post-implantation. New bone on the implant surface was 
also observed in the SHAM micro-rough surface implant at day 3. These findings are 
consistent with those reported by Schwarz et al (2007) showing bone formation as early as 
the 4th day  post implant insertion [50]. It is noteworthy that these workers used a dog model 
rather than the rat which when compared with the dog, has a faster metabolism and hence 
accelerated healing  [51]. The earliest histological evidence of bone-to-implant contact was 
seen on the SHAM micro-rough implants at Day 3, although this was only a sporadic finding 
and a limited sample size for histological analysis (n=2/group) at this timepoint. Nevertheless, 
if we consider the histological observations together with the cryo-facture analysis, which 
showed that the micro-rough surfaces had more attached tissue than the machined implants, it 
appears that the micro-rough implants were associated with accelerated tissue maturation and 
earlier surface bone formation compared to the machined implant. This is also consistent with 
previous findings that osseointegration occurs earlier on micro-rough surfaces via a process 
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of ‘contact osteogenesis’ directly on the implant, while only ‘distance  osteogenesis’ 
originating from the borders of the surgically prepared recipient bone bed is observed with 
machined surfaces (Abrahamsson et al, 2004). 
Previous studies in vitro have shown that surface topography can affect cellular 
recruitment [52] and promote osteoblast differentiation in vitro [53]. Micro-rough surface 
implants have been shown to increase osteoblastic cell attachment and differentiation [54-58] 
and result in higher osteogenic gene expression (ALP, bone sialoprotein, OC) compared with 
machined implants [59, 60]. Our study also found a significant increase in the expression of 
osteoblast markers (ALP and OC) in the SHAM micro-rough implant group, which is 
consistent with previously reported data [59] and provides further evidence that micro-rough 
surfaces have an enhanced osteogenic capacity compared to machined surfaces. However, the 
micro-rough implants in the OVX group did not show an increase in osteogenic gene 
expression despite an increase in the number and organization of osteoblasts shown 
histologically (compared to the OVX machined group). This may indicate that estrogen 
deficiency may interfere with the osteogenic capacity of osteoblasts during the early healing 
response. 
Bone remodeling is a coordinated process triggered by osteoblast and osteoclast activity. 
Osteoclasts also play an important role in the initial period after implant placement [61, 62]. 
Osteoclast activation by micro-rough titanium surfaces in vitro has been shown to be similar 
to that of bone in vivo whereas activation is reduced by smooth titanium surfaces [63].  
Furthermore, studies have shown that the gene expression of bone formation makers such as 
ALP, OC and collagen 1 is coupled with increased expression of osteoclast markers [64, 65].  
Compared with the machined implants, our data showed that the SHAM micro-rough implant 
group not only significantly increased the expression of bone formation markers such as ALP 
and OC at day 3, but also significantly increased TRAP gene expression, which is consistent 
with these previous reports [64, 65]. Interestingly in the OVX micro-rough group, the gene 
expression of RANKL rather than TRAP significantly increased at day 3. The higher 
expression of RANKL could promote osteoclasts maturation, differentiation and activation 
through activation of the RANK\RANKL\OPG pathway [66, 67]. However, expression of 
bone formation markers did not increase, suggesting the estrogen deficiency may affect the 
balance between osteoblast and osteoclast activity in the early (day 3) healing process. 
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By day 7, inflammation marker gene expression was decreased as would be expected with 
the resolution of inflammation during healing [11] , while the gene expression of osteoblast, 
osteoclast and osteocyte markers was significantly elevated compared with day 3, which was 
consistent with previous reports [64, 68]. The increase in gene expression was also consistent 
with the histological and SEM observations, which showed more bone formation and more 
mature attached tissue around the implants. 
Comparing groups at day 7, the SHAM micro-rough implants showed superior osteogenic 
capacity compared to the other groups, with increased gene expression of COL1A, RANKL 
and TRAP consistent with histological and SEM observations of increased bone formation 
and tissue maturation. OVX negatively influenced osteogenesis as COL1A expression in the 
OVX groups was found to be significantly lower than in the SHAM groups, which is 
consistent with previous clinical studies showing that high risk osteoporotic facture patients 
had lower levels of COL1A expression [54, 55]. The micro-rough implants showed some 
differences compared with the machined implants in the OVX group, with TRAP gene 
expression significantly increased. Although the TRAP expression was lower compared to 
the SHAM micro-rough implants at this time point, it reached a similar level of expression as 
SHAM machined implants. The results suggest that bone metabolism was enhanced around 
the micro-rough compared to the machined implants in the OVX group. The gene expression 
analysis was supported by both the SEM cryo-fracture and histologic assessment, which 
showed more mature tissue attached to the implant surface and more osseointegration formed 
around the micro-rough compared with machined implants. It is noteworthy that  it is difficult 
to compare the %BIC between the different groups at the 7 day timepoint because the new 
bone formation is still very limited. 
The role of osteocytes in the establishment of osseointegration was also assessed. 
Previous studies have shown that estrogen deficiency affects cancellous bone more than 
cortical bone [69, 70]. Our findings showed that ovariectomy significantly decreased the size 
of osteocytes in trabecular bone, while cortical bone was unaffected. The acid-etching 
protocol used to visualise osteocytes in this study removes mineralized tissue, leaving the 
non-mineralized and organic tissue intact. The larger lacunaes observed in the OVX group 
suggest that the lucanae contain a higher mineralised tissue content [71]. This finding is 
consitient with a recent study which showed that aged and osteoporotic conditions were 
characterised by an increase in the number and density of hypermineralized osteocyte lacunar 
[72]. These morphological changes could affect osteocyte function resulting in inferior 
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osseointegraton in the OVX groups during the early healing period.  Furthermore, the 
increased expression of the osteocyte markers DMP1 and SOST suggests that the micro-
rough surface triggers accelerated osteoblast differentiation to osteocytes. The advantages of 
the micro-rough implant were also supported by the SEM and histology observations.  
By day 14, estrogen deficiency (OVX) negatively affected the osseointegration of the 
machined implants as indicated by a reduced %BIC compared with the SHAM group. 
Osseointegration of the micro-rough implants however was relatively unaffected with 
the %BIC similar to that seen in the SHAM group, suggesting that the micro-rough surface 
compensated for the negative effect of OVX. 
By day 28, there were no significant differences among the groups in tersm 
of %BIC, %BA and mineral apposition rates (MAR), suggesting that the deleterious effects 
of machined surface topography or estrogen deficiency on osseointegration are diminished 
over time. Our results are consistent with a study which also compared three different 
surfaces (two different commercial rough surfaces c.f. a smooth surface implant) and showed 
significant differences only in the early healing time points (2 and 4 weeks), while there were 
no differences after  6 weeks [73]. The similarity in the degree of osseointegration between 
the OVX and SHAM  groups at this late time-point (28 days) is also consistent with clinical 
reports which show no significant difference in long-term implant survival rates between 
osteoporosis and healthy subjects [45, 74, 75]. 
5. Conclusions 
Both ovariectomy and implant morphology affected the early wound healing events 
associated with osseointegration. Estrogen deficiency delayed early bone healing around 
machined implants, while the micro-rough surface compensated for the negative effect(s) of 
ovariectomy by accelerating osseointegration via upregulation of the cellular and molecular 
osteogenic response.  
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Fig.1. Machined (a, b) and micro-rough (b, c) surfaced implants viewed under SEM. The 
roughness (Sa) of the implants in both implant thread valley and apex areas (red rectangles) as 
measured by 3D optical microscopy  were 518.7±15.38 nm for the machined surface implant 
(d) and 906.19±28.07 nm for the micro-rough surfaced implant (e). 
 
Fig.2. Cryo-fracture SEM and histology images of implants after 3 days of healing in the 
OVX group. The micro-rough surfaced implant showed more adherent mixed tissue 
compared to the machined implant (a, b vs. d, e), the attached mixed tissue include fibres, 
cells and amorphous matrix (b). The machined implant was covered with a thinner layer of 
tissue with clear fibres and cells (e). Histological analysis showed the micro-rough surfaced 
implant had osteoblasts organised near the old bone surface (c, yellow arrows) compared 
with the machined surface (f). 
 
Fig.3. Cryo-fracture SEM and histology images of implants after 3 days of healing in the 
SHAM group. The micro-rough surfaced implant again had more adherent tissue than the 
machined surface (a, b vs. d, e), which is consistent with the OVX results (Fig. 2). However, 
the tissue’s quality, especially the fibres in the SHAM group appears to be better than the 
OVX group (Fig. 3b vs. Fig. 2b; Fig. 3e vs. Fig. 2e). Inflammatory cells are easily visible at 
this stage (e, purple arrow). Histological images show the earliest osseointegration was seen 
in the SHAM micro-rough surface implant (d, orange arrow). 
 
Fig.4. Calcein and Alizarin red staining of day 3 new bone formation. Confocal imaging 
revealed new bone formation in SHAM group implants (a, b) and OVX rough (c) surface 
implant (green fluorescence). However, compared with the SHAM group, new bone formed 
in the OVX group is limited, which indicates early osteogenesis could be inhibited by 
ovariectomy.  OVX machined (d) surface implants showed almost no new bone formation at 
this stage. 
 
Fig.5. Cryo-fracture SEM and histology images at day 7 in OVX group. Micro-rough surface 
implants (a, b) continued to attach more tissue than the machined surface implant (d, e). The 
attached tissue became more compact and the fibres merged with each other at this stage 
compared with day 3 results (Fig. 2).  OVX rough surface implant attached more tissue than 
machined surface implant, with more osteoclast-like cells attached on the implant surface (b, 
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green arrow);  relative more blood and inflammatory  cells can still  been seen in the 
machined surface implant (e, purple arrow).  Histology images showed the rough surface 
implant (c) with more osseointegration than machined surface implant (f), both ostoblasts and 
osteoclasts are visible. 
 
Fig.6. Cryo-fracture SEM and histology images of day 7 results in the SHAM group.  More 
tissue was attached to the micro-rough surface than the machined surface implant. SHAM 
rough surface showed attached regular merged fibres, with less mixed cells than machined 
surface implant (Fig. a, b vs. e, f).  The SHAM group attached tissue clearly showed better 
quality than OVX group (Fig. 6b vs. Fig.5b; Fig. 6f vs. Fig. 5e). Histology images showed 
the SHAM rough surface implant not only has more osseointegration  than machined surface 
implant,  but also has the most mature bone compared with SHAM machined implant (g) and 
OVX group implants (Fig. 5c, f). Both osteoblasts (d) and osteoclasts (h) are visible. Yellow 
arrows show the new bone quality, orange arrows show the osteoblasts and green arrows 
show the osteoclasts). 
 
Fig.7. Day 3 gene expression analysis of early bone and inflammatory markers. ALP, OC, 
DMP1 and TRAP were significantly increased in the SHAM rough surface implant while 
RANKL and DMP1 were significantly increased in the OVX rough surface implants 
compared to the machined implants (*p<0.05, **p<0.01).  
 
Fig.8. Day 7 COL1A and DMP1 gene expression for both machined and micro-rough 
implants was significantly increased in the SHAM compared to OVX group. SHAM rough 
surface implants showed significant increases in RANKL and TRAP gene expression 
compared with other groups (*p<0.05, **p<0.01). 
 
Fig.9. Histology results at day 14. New bone was formed around the implant in all groups. 
SHAM group implant and OVX rough surface implant showed more osseintegration than the 
OVX machined surface implant (Fig.9c). Both osteoblasts (yellow arrows) and ostoeclasts 
(green arrows) are active at this stage. However, the OVX machined surface implant shows 
more osteoclasts. 
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Fig.10. Histology results at day 28. The new bone appears more mature than at day 14 (Fig. 
9). Active osteoblasts can still be seen on the new bone surface however ostoeclast numbers 
appear to be lower compared with the day 14 results. While %BIC was significantly lower in 
the OVX machined group at day 14, the effect of OVX was not apparent in the rough group 
which was similar to that seen for the SHAM groups. By day 28, there were few significant 
differences in either %BIC or BA between all the groups (c, f) (*p<0.05). 
 
Fig.11. Calcein and Alizarin red staining of new bone formation at day 28 (a,b). There was 
no difference in the mineralized apposition rate (MAR) between groups (c).  
 
Fig.12. SEM images of acid-etched resin-embedded samples showing osteocytes around 
implant. Similar images were obtained at all healing time-points. The newly formed 
osteocytes are smaller, round, less polar, and disorganized than the osteocytes in the old bone 
areas (a, c,). Osteocytes are in direct contact (circle) or indirect contact (rectangle) with the 
implant (b, d).  
 
Fig.13. The osteocyte’s body (yellow dotted circle) within the lacunae (green dotted circle) in 
the SHAM group (a, c) are larger than the OVX group (e, g) in trabecular bone area (d), 
however, there was no difference between cortical areas (b, f, h). (Blue arrows indicate the 
osteocyte/lacunae morphology). 
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Primer Sequences Used for Real-time PCR 
Genes Primers ( F = forward; R = reverse ) 
  
B2M F: 5'-CGAGACCGATGTATATGCTTGC-3' 
R: 5'-GTCCAGATGATTCAGAGCTCCA-3' 
GAPDH F: 5'-CAAGTTCAACGGCACAGTCAAG-3' 
R: 5'-ACATACTCAGCACCAGCATCAC-3' 
β-actin F: 5'-CACCCGCGAGTACAACCTTC-3' 
R: 5'-CCCATACCCACCATCACACC-3' 
ALP F: 5'-TCGGACAATGAGATGCGCC-3' 
R: 5'-TGGGAGTGCTTGTGTCTAGG-3' 
OC F: 5'-GCCCTGACTGCATTCTGCCTCT-3' 
R: 5'-TCACCACCTTACTGCCCTCCTG-3' 
COL1A F: 5'-GGAGAGAGCATGACCGATGG-3' 
R: 5'-GAATCGACTGTTGCCTTCGC-3' 
RANKL F: 5'-CATGAAACCTCAGGGAGCGT-3' 
R: 5'-GTTGGACACCTGGACGCTAA-3' 
TRAP F: 5'-CAGCCCTTATTACCGTTTGC-3' 
R: 5'-GAATTGCCACACAGCATCAC-3' 
DMP1 F: 5'-CTTTTGACCCAGTCGGAAGAGA-3' 
R: 5'-CTATTTGCCATGGGCGGTGG-3' 
SOST F: 5'-CCTTCAAGAATGATGCCACA-3' 
R: 5'-ACTCGGACACGTCTTTGGTG-3' 
TNFa F: 5'-TACTGAACTTCGGGGTGATCG-3' 
R: 5'-CCTTGTCCCTTGAAGAGAACC-3' 
IL1b F: 5'-AGCTTCAGGAAGGCAGTGTC-3' 
R: 5'-TCAGACAGCACGAGGCATTT-3' 
 
Table 1. RTPCR primer sequences. 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
